Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure

BACKGROUND: Several studies have previously demonstrated the survival benefit of both EGFR‐TKI treatment and chemotherapy in patients with non‐small cell lung cancer (NSCLC) harboring EGFR mutations. The aim of the present study was to clarify the factors influencing the treatment sequence after fai...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Thorac Cancer
Главные авторы: Mizuno, Takaaki, Horinouchi, Hidehito, Watanabe, Sho, Sato, Jun, Morita, Ryo, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons Australia, Ltd 2020
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113048/
https://ncbi.nlm.nih.gov/pubmed/32077630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13360
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы